Acquisitions 2009 In 2009 Smith & Nephew reached an agreement with the vendors of Plus to reduce the total original purchase price by CHF159m from CHF1,086m $889m at the then prevailing rates paid in May 2007.
As part of the agreement the parties have resolved their disputes on the contractual purchase price adjustments.
In addition, Smith & Nephew is releasing the vendors from substantially all of their warranties, including those relating to taxation, under the original purchase agreement and has dropped all existing .
The Group has concluded that this is a non-adjusting post balance sheet event that will be recorded by March2009.
2008 The aggregate impact of acquisitions that occurred during the year is set out below.
The acquisitions primarily relate to minority interest and distributor buyouts, as a result of the Plus acquisition concluded in 2007.
In2008, deferred considerationof$14minrespect ofthepreviousyears acquisitionswas paid.
Acquisitions continued 2007 Plus OrthopedicsHolding AG On 31 May 2007 the Group acquired 100% of the issued share capital of Plus Orthopedics Holding AG Plus, a private Swiss orthopaedic company for a total of CHF1,086m $889m in cash, including assumed debt.
This has been integrated into the Groups Orthopaedics business segment.
At 31 December 2007 the cost of the Plus acquisition was allocated on a provisional basis to the assets acquired and liabilities assumed on acquisition.
In 2008, fair value adjustments were revised to reflect improved knowledge of the Plus business.
The final allocation of the purchase price that was completed by 31 May 2008 in accordance with the time line stipulated in IFRS 3 Business Combinations and the balance sheet as at 31 December 2007hasbeenadjusted as follows: Fairvalueto Fairvalueto Pre-acquisition Provisional Group Group carrying fairvalue reported in Finalfairvalue reported in amounts adjustments 2007 adjustments 2008 $ million Property, plant andequipment... 81 2 79 1 78 Intangibleassets acquisition intangibles................ 240 240 27 213 Intangibleassets other...... 10 8 2 2 Investments inassociates...... 6 4 10 10 Deferred taxation assets....... 19 19 Inventories.................. 106 66 172 3 169 ..... 128 128 15 143 Loansandborrowings......... 181 181 181 Deferred taxation liabilities...... 4 34 38 7 31 Retirement benefit obligation.... 6 16 22 22 ...... 125 4 129 16 145 Netassets................... 34 227 261 25 236 Equityattributable tominorityinterests i................ 4 4 .............................. 463 25 488 Cost ofacquisition.................................. 720 720 Dischargedby: Cash............................................. 726 726 CashacquiredinPlus............................... 18 18 Costs associated withacquisition...................... 12 12 720 720 i The  amountoftheequity $4m.
Management believes that goodwill represents the value of the workforce, the existing European corporate  areexpected .
In 2007, from the date of acquisition on 31 May 2007, Plus products contributed $200m to revenue.
It was impractible to calculate Plus contribution to attributable profit in 2007, since its acquisition by the Group, as .
ii These companies wereconsolidated  todeferred purchase consideration agreements.
Subsequent to the Plus acquisition the Group acquired Plus Australian distributor and the minority interests in the Netherlands and Greece for a total of $13m in cash and $6m of contingent consideration.
This was allocated as inventoryof$3m, goodwillof$ of$4m.
In addition to the above, the Group acquired Plus minority interest in Plus Orthopedics GmbH Germany andtherebysettled deferred $25m.
BlueSky Medical Group, Inc On 10 May 2007, the Group acquired 100% of the issued share capital of BlueSky Medical Group Inc. BlueSky for an initial payment of $15m with further milestone payments of up to $95m related to revenues and other events.
The company developed products for treating chronic wounds using negative pressure wound therapy and marketed a range of negative pressure pumps and wound dressing kits.
This has been integrated into the Groups Advanced Wound Management business segment.
BlueSkys assets  at fairvalueat thedate ofacquisitionas follows: Pre-acquisition carrying Fairvalue Fairvalue amounts adjustments toGroup $ million Intangibleassets .............. 26 26 Inventories........................................ 2 2 .......................... 1 1 ............................ 3 3 Deferred taxation liabilities........................... 10 10 Netassets........................................ 16 16 ...................................................... 34 Cost ofacquisition.......................................................... 50 Dischargedby: Cash..................................................................... 15 Costs associated withacquisition.............................................. 1 Present valueofprobable milestonepayments................................... 34 50 In addition to the cash consideration of $15m, the Group is committed to paying future milestone payments totalling $95m on the achievement of certain milestones.
The Group assessed the present value of the probable milestonepayments tobe $34m.
Acquisitions continued Management believes that the goodwill arising on the acquisition of BlueSky represents the synergies expected tobe achieved.
In 2007, from the date of acquisition on 10 May 2007, BlueSky contributed $6m to revenue and a loss of $10mtoattributable profitfortheyear.
Total 2007 acquisitions Had all the acquisitions in 2007 occurred at the beginning of the year the revenue of the combined Group would have been $3,526m and attributable profit, including the results of the acquired companies adjusted for amortisation of acquisition intangibles, utilisation of inventory step-up, the interest expense on debt incurredas result  thereon, wouldhavebeen$295m.
In addition $792m, , deferred consideration of$7minrespect ofpreviousyears acquisitionswas paidin2007.
2006 On 10 July 2006, the Group acquired 100% of the issued share capital of OsteoBiologics Inc. OBI a company providing bioabsorbable implants for bone healing for a net cost of $73m settled in cash.
OBI has been integrated with the Endoscopy business.
This acquisition gave the Group access to intellectual property and technology for use in cartilage repair and management believes that goodwill represents the  areexpected toarisefortheGroup.
During 2008 the Group recorded an impairment charge of $14m against one of the intangible assets acquiredas part ofthisacquisition.
In 2006, from the date of acquisition on 10 July 2006, OBI contributed $3m to revenue and a loss of $3m to attributable profit for the year.
Had the acquisition occurred at the beginning of the year the revenue of the $ $743m.
In addition to the cash consideration of $73m, deferred consideration of $10m in respect of previous years acquisitionswas paidintheyear.
